Elutia (ELUT) Non-Current Deffered Revenue (2019 - 2021)
Elutia (ELUT) reported Non-Current Deffered Revenue of $936000.0 for Q3 2021, up 77.61% on a YoY basis from $527000.0 in Q3 2020, and up 7.59% sequentially from $870000.0 in Q2 2021.
Elutia (ELUT) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Elutia (ELUT) has 3 years of Non-Current Deffered Revenue data on file, last reported at $936000.0 in Q3 2021.
- For the quarter ending Q3 2021, Non-Current Deffered Revenue rose 77.61% year-over-year to $936000.0; the trailing twelve-month figure through Sep 2021 stood at $936000.0 (up 77.61% YoY), and the FY2020 full-year result was $756000.0, up 7.23% from the prior year.
- Non-Current Deffered Revenue climbed to $936000.0 in Q3 2021, from $870000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $936000.0 in Q3 2021 to a low of $527000.0 in Q3 2020.
- A 3-year average of $770666.7 and a median of $793000.0 in 2020 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue rose 7.23% in 2020 and jumped 77.61% in 2021, its largest moves.
- Tracing ELUT's Non-Current Deffered Revenue over 3 years: stood at $705000.0 in 2019, then climbed by 7.23% to $756000.0 in 2020, then grew by 23.81% to $936000.0 in 2021.
- Business Quant data shows ELUT's Non-Current Deffered Revenue at $936000.0 in Q3 2021, $870000.0 in Q2 2021, and $830000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 936,000.00 |
| Jun 30, 2021 | 870,000.00 |
| Mar 31, 2021 | 830,000.00 |
| Dec 31, 2020 | 756,000.00 |
| Sep 30, 2020 | 527,000.00 |
| Dec 31, 2019 | 705,000.00 |